When the investigators examined the impact of the type of therapy used, they found that 30.6% of patients who received anti-CD20 therapy plus chemotherapy had an SPM compared with 21.9% of ...

Background: Cases of SPM have been reported following CAR T therapy, but comparative studies are scarce. We compared the risk of SPM following CAR T therapy vs other SACT in pts with MM. Methods: Pts ...